WILSON TROY EDWARD
CIK 1589597
Transactions on file
23
Open-market buys
5
Win rate (buys)
60%
5 scored
Avg % since filing (buys)
+18.2%
Tickers traded
Recent activity
| Filed | Txn date | Issuer | Roles | Code | Shares | Value | % since Filing | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-09-17 | 2026-09-14 | PBYI PUMA BIOTECHNOLOGY, INC. | Director | Sale | 5,000 | $45.5K | +15.6% | open → |
| 2026-08-25 | 2026-08-24 | KURA Kura Oncology, Inc. | President and CEO | Buy | 100,000 | $1.24M | -22.4% | open → |
| 2026-08-17 | 2026-08-17 | KURA Kura Oncology, Inc. | President and CEO | Buy | 100,000 | $1.11M | -13.5% | open → |
| 2026-06-16 | 2026-06-12 | PBYI PUMA BIOTECHNOLOGY, INC. | Director | Sale | 10,800 | $77.7K | +46.1% | open → |
| 2026-06-16 | 2026-06-11 | PBYI PUMA BIOTECHNOLOGY, INC. | Director | Grant | 27,000 | $0.00 | — | open → |
| 2025-06-12 | 2025-06-10 | RNA Avidity Biosciences, Inc. | Director | Grant | 6,692 | $0.00 | — | open → |
| 2025-06-13 | 2025-06-11 | PBYI PUMA BIOTECHNOLOGY, INC. | Director | Grant | 27,000 | $0.00 | — | open → |
| 2025-06-17 | 2025-06-13 | PBYI PUMA BIOTECHNOLOGY, INC. | Director | Sale | 10,800 | $36.7K | +209.4% | open → |
| 2025-11-14 | 2025-11-13 | KURA Kura Oncology, Inc. | President and CEO | Grant | 182,500 | $0.00 | — | open → |
| 2025-08-08 | 2025-08-06 | RNA Avidity Biosciences, Inc. | Director | Exer. | 22,000 | $264.7K | -33.5% | open → |
| 2025-08-08 | 2025-08-06 | RNA Avidity Biosciences, Inc. | Director | Sale | 17,777 | $800.0K | -82.2% | open → |
| 2025-08-08 | 2025-08-06 | RNA Avidity Biosciences, Inc. | Director | Sale | 22,000 | $990.0K | -82.2% | open → |
| 2025-08-08 | 2025-08-06 | RNA Avidity Biosciences, Inc. | Director | Exer. | 7,500 | $93.6K | -35.9% | open → |
| 2025-08-08 | 2025-08-06 | RNA Avidity Biosciences, Inc. | Director | Sale | 7,500 | $337.5K | -82.2% | open → |
| 2025-08-08 | 2025-08-06 | RNA Avidity Biosciences, Inc. | Director | Sale | 15,000 | $675.0K | -82.2% | open → |
| 2025-08-14 | 2025-08-13 | KURA Kura Oncology, Inc. | OfficerDirector President and CEO | Buy | 13,494 | $89.6K | +44.9% | open → |
| 2025-08-14 | 2025-08-12 | KURA Kura Oncology, Inc. | OfficerDirector President and CEO | Buy | 36,506 | $213.6K | +64.4% | open → |
| 2025-09-09 | 2025-09-08 | KURA Kura Oncology, Inc. | OfficerDirector President & CEO | Buy | 50,000 | $410.0K | +17.3% | open → |
| 2025-09-09 | 2025-09-05 | RNA Avidity Biosciences, Inc. | Director | Sale | 14,500 | $725.0K | -84.0% | open → |
| 2025-09-09 | 2025-09-05 | RNA Avidity Biosciences, Inc. | Director | Sale | 15,000 | $750.0K | -84.0% | open → |
| 2025-09-09 | 2025-09-05 | RNA Avidity Biosciences, Inc. | Director | Exer. | 14,500 | $181.0K | -35.9% | open → |
| 2025-09-29 | 2025-09-29 | KURA Kura Oncology, Inc. | OfficerDirector President and CEO | Sale | 36,615 | $327.3K | +7.6% | open → |
| 2025-09-29 | 2025-09-27 | KURA Kura Oncology, Inc. | OfficerDirector President and CEO | Grant | 182,500 | $0.00 | — | open → |
